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Abstract
Background: Regular physical activity reduces the risk of mortality from all causes, with a powerful beneficial effect
on risk of falls and hip fractures. However, physical activity levels are low in the older population and previous
studies have demonstrated only modest, short-term improvements in activity levels with intervention.
Design/Methods: Pragmatic 3 arm parallel design cluster controlled trial of class-based exercise (FAME), home-
based exercise (OEP) and usual care amongst older people (aged 65 years and over) in primary care. The primary
outcome is the achievement of recommended physical activity targets 12 months after cessation of intervention.
Secondary outcomes include functional assessments, predictors of exercise adherence, the incidence of falls, fear of
falling, quality of life and continuation of physical activity after intervention, over a two-year follow up. An
economic evaluation including participant and NHS costs will be embedded in the clinical trial.
Discussion: The ProAct65 trial will explore and evaluate the potential for increasing physical activity among older
people recruited through general practice. The trial will be conducted in a relatively unselected population, and
will address problems of selective recruitment, potentially low retention rates, variable quality of interventions and
falls risk.
Trial Registration: Trial Registration: ISRCTN43453770
Background
The health benefits of physical activity have been exten-
sively reviewed and evidence suggests that it reduces the
risk of cardiovascular disease, type 2 diabetes, osteo-
porosis and certain cancers [1]. There is growing evi-
dence of the association between regular physical
activity and a reduced risk of all cause mortality [2], and
of the potential savings for NHS budgets from exercise
promotion for older adults [3]. Sedentary behaviour
increases the risk of dependence, falls and fractures.
Sustained levels of physical activity in adulthood
maintain bone strength and can prevent fragility frac-
tures in later life. Research has shown that a lifetime’s
history of regular physical activity can reduce the risk of
hip fracture by up to 50% and much of this benefit is
t h o u g h tt or e s u l tf r o mar e d u c t i o ni nf a l l s[ 4 ] .I ti sn o w
clear that habitual physical activity and improved access
to exercise opportunities is an important public health
approach to the prevention of functional decline that
can lead to frailty, falls and fractures [5].
Falls are common in people aged 65 years and older
and can have serious consequences, including injury,
pain, impaired function, loss of confidence in carrying
out everyday activities, loss of independence and auton-
omy, and even death [6,7]. There is evidence that
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effective in preventing falls amongst older people [8]
and that healthcare costs [9,10] can be reduced if falls
are reduced [11-15].
Current recommendations for health benefits are that
people do at least 30 minutes of physical activity of
moderate intensity on at least five days of the week [16].
However, surveys have consistently shown a high preva-
lence of physical inactivity in the UK population [17]. A
recent systematic review comparing seventeen rando-
mised controlled trials with different interventions
designed to encourage sedentary, community dwelling
adults to do more physical activity [18] concluded that
interventions were effective in the short and mid term,
at least in middle age, and that there were no significant
increases in adverse events in the four studies that
reported them. However, it is unclear which individual
interventions (e.g. home-based or facility-based) are the
most effective in increasing physical activity in the long
term, or in specific groups (e.g. older people).
The NHS is attempting to address the problem of inac-
tivity in a variety of ways, including exercise referral
schemes in primary care (’exercise on prescription’) which
are currently provided by approximately 89% of Primary
Care Trusts and usually involves referring patients to local
leisure centres [19]. Although exercise on prescription has
been shown to be feasible and effective in vulnerable older
people [20], there appear to be significant barriers to the
uptake of exercise classes in leisure centres. For many
older people home exercise or group exercise in non-inti-
midating environments (e.g. community halls) may be
more appealing, and result in higher uptake of exercise
programmes and longer continuation of exercise. Peer
activity mentors have also been shown to be effective in
increasing uptake and adherence to exercise [21-24].
There are currently two existing exercise programmes,
designed for use in community settings, specifically for
people aged 65 and over. The first is a home based pro-
gramme known as the Otago Exercise Programme
(OEP) and the second is a community based group exer-
cise programme known as the Falls Management Exer-
cise Programme (FaME).
The OEP (Otago Exercise Programme) [25-31] and
FaME (Falls Management Exercise) programmes [32]
were both designed for use in community settings. spe-
cifically for people aged 65 and over. As well as being
designed to reduce falls, both are based on the compo-
nents of fitness and principles of programming for all
older adults (i.e. warm up, mobility, stretches, strength
and balance, endurance and a cool-down) and have all
the elements of training appropriate for that age group.
Exercises are tailored to the individual’s ability and
health need. Both programmes involve strength &
balance training which is tailored to the individual’s
ability and health need.
The OEP is a home based exercise programme for
older people which is effective in reducing the falls and
fall-related injuries, improving balance, strength and
confidence in performing everyday activities without
falling, and has been shown to be cost effective for peo-
ple aged 80 and over [25-31]. It was designed to be
delivered by physiotherapists and nurses trained and
supervised by physiotherapists. A one year evaluation of
the OEP showed considerable improvements in outdoor
activities (walking, shopping, gardening, other outside
leisure activities) after 6 months (unpublished data
Campbell) with participants continuing to exercise after
completing the programme. It also showed significant
improvements in executive function after 6 months [30].
Whilst the OEP has been evaluated in four controlled
trials of older primary care patients in New Zealand and
one RCT in Canada, it has not been tested in a primary
care setting in the UK for its feasibility, impact, accept-
ability and cost-effectiveness.
FaME is a group exercise programme which was
developed and tested in a controlled trial in the UK
[32], but not in a primary care population. It aims to
improve balance [33] and was designed to be delivered
by qualified postural stability instructors (PSIs) [34]. It
has been shown to be effective in reducing falls and
injuries resulting from falls [32]. Good compliance was
demonstrated with the FaME programme and nearly
two thirds of people participating in FaME continued in
group exercise programmes for over a year after trial
completion. (unpublished data Skelton). FaME now
needs to be evaluated for its impact, acceptability and
cost-effectiveness within primary care.
This trial aims to fill the gaps in the current evidence
base by evaluating the delivery, impact, acceptability and
cost-effectiveness of a community based exercise pro-
gramme (FaME) and a home based exercise programme
(OEP) supported by similarly aged (peer) mentors, com-
pared with usual care for primary care patients. The
underlying assumption is that the exercises will produce
sufficient subjective well-being and improved mobility to
encourage continuation of higher levels of physical
activity after the cessation of the intervention. Each
exercise programme will be compared with usual care
for effectiveness in producing sustained change in physi-
cal activity. The two programmes will be compared for
cost-effectiveness if both are effective in promoting sus-
tained change in physical activity. The primary hypoth-
eses are: 1) Both exercise programmes produce
sustained changes in physical activity (PA) compared
with usual care, and 2) The Otago programme (OEP) is
more cost effective than FaME
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The primary objective is to determine the effect of two
evidence based exercise programmes designed for older
people, compared with usual care (i.e. with no special
interventions to promote physical activity) on the
achievement of recommended physical activity targets
12 months after cessation of intervention.
The secondary objectives are to:
(1) determine the health benefits of the programmes
to participants starting at various levels of physical activ-
ity, particularly the effects on physical and psychological
status, health status, health-related quality of life and
quality adjusted life years (QALYs).
(2) estimate the costs of the exercise interventions,
and possible cost offsets, and to assess the cost-effective-
ness of community group exercise, and home-supported
exercise compared with each other, and with usual care.
(3) determine the acceptability of the programmes,
adherence rates, enabling factors and barriers to future
implementation.
(4) compare the time course of responses by partici-
pants in terms of exercising at the recommended levels,
at 0, 6, 12, 18 and 24 months after cessation of the
intervention, between those undergoing the exercise
programmes, and those receiving usual care.
(5) determine participants’ perceptions of the value of
exercise, and the predictors of continued exercise.
Design/Methods
A 3 arm parallel design cluster controlled trial using
minimisation for allocation at the level of general practice
in two centres (London and Nottingham/Derby), com-
paring community-centre based group exercise pro-
gramme (FaME), with a home based exercise programme
and walking plan (OEP) and with usual care. There will
be two years’ follow-up to determine the impact, accept-
ability and adherence to the programme, longer term
continuation of exercise and cost-effectiveness. The
CONSORT diagram [35] summarises the design (Fig 1).
Participants
Participants will be patients aged 65 years and over
registered with participating general practices who give
informed consent to participate.
Inclusion criteria for practices
Inclusion criteria will be a commitment to participate over
the duration of the study and the availability of a suitable
community venue in the practice catchment area.
Inclusion criteria for participants
Those aged 65 years and older, who can walk around
independently of personal help both indoors and out-
doors (with or without a walking aid) and who would be
physically able to take part in a group exercise class, will
be eligible to participate.
Exclusion criteria for participants
Those with any of the following criteria will be
excluded:
￿ Three or more self-reported falls in the previous
year;
￿ Resting BP > 180/100 mmHg; tachycardia > 100
bpm; those considered by their GP to have uncontrolled
hypertension; significant drop in BP during exercise
recorded in the medical records or found at initial
assessment;
￿ Psychiatric conditions which would prevent partici-
pation in an exercise class, e.g. psychotic illness;
￿ Uncontrolled medical problems, which the GP con-
siders would exclude patients from undertaking the
exercise programme; e.g. acute systemic illness’ such as
pneumonia, poorly controlled angina, acute rheumatoid
arthritis, unstable or acute heart failure;
￿ Conditions requiring a specialist exercise pro-
gramme, e.g. uncontrolled epilepsy, significant neurolo-
gical disease or impairment; unable to maintain seated
upright position or unable to move about independently
indoors;
￿ Not living independently (e.g. residential or nursing
care);
￿ Significant cognitive impairment (unable to follow
simple instructions);
￿ Already receiving long term physiotherapy or already
in an exercise programme.
Exclusion criteria will be checked at the recruitment
appointment by the researcher. This will include measure-
ment of resting BP and pulse and completion of a health
questionnaire. The participant’s GP will be asked to con-
firm eligibility for each potentially eligible participant.
Recruitment of practices
General practices will be recruited from the Primary
Care Research Networks (PCRN) in London and Not-
tingham/Derby. The PCRNs will be asked to identify
potential participant practices by size and deprivation
status. Approaches by mailed invitation, telephone con-
tact with practice managers, and personal contact with
local GP opinion leaders all be used as necessary [36].
Recruitment of participants
Practices will produce a single numbered list of patients
aged 65 and over. Practice staff will be allowed to make
and justify their own exclusions in liaison with the
research team. The research team will provide the prac-
tices with a random number list to select the sample of
patients to be approached after exclusions have been
made. The sampling will vary depending on practice
size. In practices with fewer than 600 patients aged 65
and over, all patients aged 65 and over will be invited to
participate. In larger practices random sampling will be
used to identify 600 patients aged 65 and over who will
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tation letters about the trial by their usual General
Practitioner.
Interventions
There are 3 arms to the trial:
(1) home based exercise programme and walking plan
(OEP)
(2) community-centre based group exercise pro-
gramme (FaME)
(3) usual care
Home based exercise programme (OEP)
This consists of a 30 minute programme of leg muscle
strengthening and balance retraining exercises progres-
sing in difficulty to be performed at home at least three
times per week, and a walking plan to be undertaken at
least two times per week for 24 weeks. Each participant
will receive an instruction booklet and ankle cuff
weights (starting at 0.5 kg) to provide resistance for the
strengthening exercises. The programme will be intro-
duced to participants by trained research staff, at an
appropriate starting level determined at an initial assess-
ment. Trained peer mentors will contact and visit the
participants at home to start the exercise programme
with them and will follow-up with up to three more
home visits (as the participants require). Participants
will record the days they complete the programme, and
mentors will telephone them fortnightly as mentor sup-
port has been shown to be effective in increasing adher-
ence [21-23]. Mentors will record and report any
problems encountered with the exercise programme to
Figure 1 Consort flowchart for cluster randomised trials; potential flow of participants.
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oped for the study.
The delivery of the OEP will be standardised through
training of research staff before the trial starts and there
will be regular contact with the participants and peer
mentors to check delivery protocols are being followed.
Community based exercise programme (FaME)
The FaME programme comprises one hour-long PSI-
delivered group exercise class in a local community cen-
tre for a maximum of 15 participants, and two 30 minute
home exercise sessions (based on the OEP) per week for
24 weeks. Participants will be advised to walk at least
twice per week for up to 30 minutes at a moderate pace.
The programme includes leg muscle strengthening and
balance retraining that progress in difficulty. Progressive
trunk and arm muscle strengthening, bone loading,
endurance (including walking) and flexibility training,
functional floor skills (see below) and adapted Tai Chi
complete the evidence based programme. Ankle cuff
weights, Therabands (elastic resistance training bands)
and mats are also used throughout the programme. The
group exercises include retraining of the ability to get up
from the floor and floor exercises to improve strength,
balance and coping strategies to reduce the risk of com-
plications resulting from a long lie [34].
The delivery of the FaME programme will be standar-
dised through training of PSIs before the trial starts and
t h e r ew i l lb er e g u l a rq u a l i t ya s s u r a n c ev i s i t sf o rt h e
FaME classes to check delivery protocols are being
followed.
The PSI will keep a register of attendance and record
tailoring of the programme and any feedback from par-
ticipants. They will follow up non-attenders by tele-
phone as necessary, recording any positive or negative
feedback, and notify the research team about reasons for
non-attendance or drop-out. Participants will be given a
booklet containing their home exercise instructions.
FaME groups will contain 9 or 10 participants, so
there will be 4 or 5 classes per week for each of the
practices allocated to this arm. The number of PSIs run-
ning these classes will be determined by their availabil-
i t y ,b u tt h ea i mi st om a x i m i s ec o n t i n u i t ya n d
standardisation in physical activity training, so the ideal
would be to have one PSI who would lead all groups in
one practice. This may be difficult to achieve, but we
will report the actual deployment of PSIs in our find-
ings. The same applies to peer mentors for OEP classes
General practitioners in participating practices allo-
cated to either the FAME or OEP programmes will be
discouraged from referring participants involved in the
trial to other exercise therapy projects, outside the study.
Usual care
Participants in the usual care arm will not be offered
either the OEP or FAME programmes. They will be free
to participate in any other exercise as they would if they
were not participating in the trial.
Cultural and ethnic sensitivity
Cultural and religious requirements will be accommo-
dated within the exercise programmes. The recommen-
dations from the Help the Aged Minority Ethnic Elders
Falls Prevention Programme (MEEFP:http://www.help-
theaged.org.uk/meefp) will be followed and the research
team will liaise closely with Skills Active (Sector Skills
Council for Active Leisure and Learning), who are work-
ing with the Integrated Fitness Initiative’s (IFI) current
programme: Physical Activity Provision for Ethnic Min-
ority Groups. In particular the FaME group classes will
ensure that recommendations for attire will respect cul-
tural, religious beliefs and customs for a range of ethnic
groups. Single sex exercise groups will be scheduled as
required, and separate changing facilities and gender
specific instructors will be provided wherever possible.
Windows in the exercise classrooms will be screened as
appropriate. Family support will be encouraged, and
classes will be provided at different times of the day The
OEP programme will respect participant’s preferences
regarding family support and participation in the home
exercise programme.
All research material and exercise manuals will use a
maximum reading age of 9 years. Inability to read the
material is not a formal exclusion criterion as the indivi-
d u a lm a yb ea b l et of o l l o wm o v e m e n ta n dc o r r e c t i o n
accurately in classes and family members will be allowed
to act as interpreters. Where possible, translations of
research material and exercise manuals will be provided.
Outcome measures
The primary and secondary outcome measures have
been chosen to reflect the needs of participants (e.g.
functional outcomes, falls, confidence, quality of life,
participant costs), of commissioners of exercise services
in primary care and policy makers (e.g. physical activity,
falls, NHS costs).
T h ep r i m a r yo u t c o m ew i l lb et h ep r o p o r t i o nr e a c h -
ing the recommended physical activity (PA) target of
at least 30 minutes of activity of moderate intensity on
at least 5 days each week, measured using the
CHAMPS, PASE and PHONE_FITT questionnaires.
While measures will be taken at 0, 6, 12, 18 and 24
months after the intervention, our primary analysis will
be of 12 month data, as this is the time when the
effect of the intervention is expected to be maximal, as
seen in a previous evaluation of the OEP in New Zeal-
and [37].
The secondary outcomes will include:
(1) The direct health benefits: i.e. functional and psy-
chological status, the rate of falls (the major safety out-
come measure), the number and nature of falls, and fear
of falling,
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sical self-perception (self-esteem relative to the physical
domain), which includes measurement of perceived
importance (the degree to which participants value their
physical condition, body image and physical strength) to
inform predictors of exercise adherence and continua-
tion, and participants’ judgement of the value or impor-
tance of physical activity,
(3) Health - related quality of life and Quality adjusted
life years (QALYs) [38],
(4) The NHS and private (participant) costs of each
exercise programme, and possible cost offsets, identified
from a comparison of health and social service utilisa-
tion of participants in all groups during the study
period.
Ascertainment of outcomes
The following functional assessments will be used by
researchers at baseline and at the end of the interventions
(and at 6 months after allocation in the usual care arm):
1. Modified Clinical Romberg Static Balance test, eyes
open and closed [39].
2. Timed get-up and go (with and without distraction)
(TUG) as a measure of balance and falls risk [40].
3. Functional Reach as a measure of balance and falls
risk [41].
4. 30 second chair rise as a measure of lower limb
strength and power [42].
The following validated tools will be used at baseline,
and as self-completion questionnaires at follow-up:
1. Confidence in balance measured by the ConfBal
scale [43]. A total score is provided as a measure of
confidence.
2. Confidence in carrying out a range of basic activ-
ities of daily living without falling measured by the Falls
Efficacy Scale-International (FES-I) [44].
3. Readiness to change measured by the transtheoreti-
cal model [45] and applying it to exercise behaviour to
determine perceived barriers [46] and self efficacy for
exercise [47].
4. Quality of life will be measured using Older Peo-
ple’s QoL Questionnaire (OPQOL) [48-50]
5. Social network size and density will be measured
using the brief Lubben Social Network scale [51] and
perceived social support measured by the Multidimen-
sional Scale of Perceived Social Support (MSPSS) [52].
6. Subjective Habitual Physical Activity will be
assessed using a number of validated questionnaires to
ensure all domains of activity and sport are considered,
including the Phone-FITT, PASE and CHAMPS [53-55]
and the current level of activity questions used in the
Household Survey [56].
7. Attitudes and beliefs about falls prevention inter-
ventions will be measured using the AFRIS question-
naire [57].
8. Falls risk will be measured by the Falls Risk Assess-
ment Tool (FRAT) [58].
9. Health- related quality of life will be measured by
the SF-12 [59]. Quality Adjusted Life Years (QALYs),
which are the main outcome for the economic analysis,
will be based on EQ-5D utility weights obtained by
transforming SF-12 scores [38].
In addition, demographic information, co-morbidity,
medication, use of general practice and hospital and
community social services will also be recorded at base-
line and updated at subsequent assessments. Falls will
be ascertained by self-completed fall diaries, with follow
up of non-responders and telephone contact with fallers
to ascertain the type of fall and any injury and health
care usage that resulted.
Feedback will be sought from all exercise participants
using a questionnaire which will include open questions
eliciting views of the programme, reasons for drop-out,
barriers to attendance and self perceptions of the bene-
fits and disadvantages of the programmes to aid future
implementation.
For the purposes of the economic analysis, the
resources used in the delivery of the interventions will
be collected from records kept by PSI instructors
(FaME) and the research staff and peer mentors (OEP).
The use of facilities and equipment, and the time spent
on travel and instruction will be included and monetary
costs will be assigned according to market rates.
In addition, the use of health and social care services
(GP, community, outpatient, hospital admission) will be
recorded for participants in all groups by means of the
falls diaries. Self reported service utilisation will be veri-
fied from the primary care medical records of consent-
ing patients after the follow up period. Costs of services
will be obtained from local and national sources [60].
Health and social care costs in the exercise groups will
be compared with each other and with the usual care
(no exercise) group to assess the extent to which the
costs of the exercise intervention may be offset by sav-
ings elsewhere in the health and social care system.
No other encouragement to continue with physical
activity will be given to participants, and all potential
reinforcements in the form of diaries and six monthly
contracts will be given to all three arms of the trial.
Baseline data collection
Baseline assessment will include all functional assess-
ments plus administration of all questionnaires
described above.
Follow-up data collection
Follow up assessments occur at 24 weeks after the com-
mencement of the intervention, and at 6, 12, 18 and 24
months after the completion of the intervention for par-
ticipants in both intervention arms, and at 24 weeks
after randomisation and at 6, 12, 18 and 24 months
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trol arm.
The 24 week functional assessment will be identical to
the baseline assessment plus administration of all ques-
tionnaires described above.
Assessments at 6, 12, 18 and 24 months after comple-
tion of the intervention or after completion of the 24
week assessment in the control arm will comprise postal
administration of the questionnaires described above.
The primary end-point will be the proportion reaching
the recommended physical activity (PA) target of at least
30 minutes of activity of moderate intensity on at least 5
days each week, measured using the CHAMPS, PASE
and PHONE_FITT questionnaires, at 12 months after
intervention.
Sample size
Sample size estimates are based on the numbers of par-
ticipants needed to detect differences in proportions of
participants in intervention and control groups:
1) Participating in physical activity (defined as reach-
ing the national target recommendations of five sessions
of 30 minutes or more of at least moderate activity per
week).
2) Self perceived health as measured by the EQ-5D
index, from which meanQALY scores and the incremen-
tal cost-effectiveness ratio will be calculated.
Under individual randomisation, sample size calcula-
tions for a small effect size (0.3) [61] equivalent to a
mean difference of 0.05 in the EQ-5D index in general
community samples requires 176 participants per study
group [62]. Published evidence of participants in a clus-
ter randomised trial of physical activity promotion
showed the proportions of participants achieving the
same recommended targets for physical activity to be
14.6% (intervention subjects) vs. 4.9% (control subjects)
[63]. A total of 215 participants in each study group are
required to detect this difference between study groups
with 90% power (5% 2-sided significance). Current plans
seek a 1% increase in the number of people achieving
the physical activity target of five sessions of 30 minutes
or more of at least moderate activity per week, year on
year [1].
Data from 24 general practices in the British Regional
Heart study suggested that an intra-class correlation
coefficient (ICC) not exceeding 0.02 was appropriate for
physical activity outcomes among middle aged men, but
this study aimed to represent the full range of cardiovas-
cular disease prevalence across Britain and the range
would probably be less in the proposed study as it is
less geographically dispersed [64]. Also ICCs collected
for a range of variables in primary care settings have
typically averaged 0.01 [65].
Based on an intra class correlation coefficient of 0.01
the design effect would be 1.31, because 32 participants
will provide data per practice (see next paragraph). If
215 participants per arm are required (before allowing
for attrition) for an individually randomised design (90%
power, 5% 2-sided significance), 282 per arm would be
required for the clustered design. Allowing for 30% attri-
tion, this equates to 403 per arm. The sample size is
based on detecting differences between each interven-
tion (exercise programme) and the control arm, and
there is unlikely to be enough power to detect modest
differences in outcome between the two intervention
arms.
Assuming an average practice size of 6000 patients,
15% (900) of whom are aged 65 and over [66] and a
random 1 in 2 sample (ratio will vary according to the
practice size) of patients are approached to take part in
the study, 600 patients aged 65 and over would be
approached. Assuming that approximately 45 of these
patients per practice agree to participate, and allowing
for an attrition rate of 30%, outcome data would be
obtained on 32 participants per practice.
It is expected that all or most patients in each practice
will be invited to join the trial. In larger than average
practices, however where the patient list is very large, a
stratified random sample of 600 patients will be drawn.
Response rates from each practice will be recorded.
Randomisation
Due to the relatively small number of practices in the
trial, minimisation will be used to allocate practices to
treatment arms to ensure maximum balance [67]. After
all participants from a practice have been recruited,
their practices will be individually allocated to a study
arm by the London co-ordinating centre. Practices will
b eg i v e na ni d e n t i f i c a t i o nn u m b e ra n dt r e a t m e n t sw i l l
be assigned, by the senior statistician for the trial, using
computer generated random number tables, embedded
in a computer programme for minimisation. The vari-
ables to be used in the minimisation process will be trial
centre (London/Nottingham & Derby), practice size (>=
median practice size/< median practice size) and the
index of multiple deprivation 2007 [68] (>= median
IMD2007/< median IMD2007). Minimisation will be
undertaken using the MINIM program [69]. Practice
recruitment and allocation will be performed concur-
rently in the two centres. Median practice size and
IMD2007 values for the whole of England will be used
as cutpoints for the minimisation process.
Concealment of allocation
Practices are allocated to intervention or usual care only
after all patients are recruited. The practices, their
patients and the researchers undertaking baseline assess-
ments are all blinded to allocation until this point.
Blinding
It is difficult for participants to be blind in trials of exer-
cise interventions, and for researchers to be blind to the
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and undertake baseline and follow up assessments. The
researchers assessing outcomes are not blinded for prag-
matic reasons only; the study is funded to support only
enough researchers to carry our recruitment and follow-
up simultaneously. However, general practices and their
participants, and researchers having contact with prac-
tices and participants will not have foreknowledge of the
treatment arm allocation of the practice, which will not
be disclosed until after all participants within a practice
have been recruited. Also, for the statistical analysis of
participants’ data, the statistician will be blind to the
treatment arm allocation of the practices.
Withdrawals
Participants may be withdrawn from the trial either at
their own request or at the discretion of the Investigator
after discussion with the chair of the trial steering com-
mittee. Participants will be made aware (via the informa-
t i o ns h e e ta n dc o n s e n tf o r m )t h a tw i t h d r a w a lf r o mt h e
trial will not affect their future care, and that the data
collected to date may still be used in the final analysis.
Any requests to withdraw data made by individuals
withdrawing from the trial will be respected. The
research teams at each site will advise discontinuation of
exercise intervention or withdrawal from the trial if the
exercise intervention poses a hazard to the safety of a
participant, or if the participant poses a hazard to the
safety of another participant. Those who withdraw from
the trial will not be replaced.
Contamination
Usual care arm participants may be disappointed and
seek their own way of increasing physical activity, but
the falls and service use diaries and the 6 monthly
reviews will capture this information.
Statistical methods
Characteristics of participants and practices will be com-
pared descriptively at baseline. Comparisons between
treatment arms will be made using random effects mod-
els to allow for clustering between practices. Linear
regression models will be used for continuous outcome
variables, logistic models for binary outcome variables
(in particular the primary endpoint, namely attainment
of recommended exercise level at 12 months after the
intervention), and Poisson or negative binomial models
for data on rate of falls. The assumptions for using each
model will be checked and analyses adjusted accord-
ingly. All analyses will be undertaken, adjusted (a) for
variables used for minimisation (centre, deprivation and
practice size), (b) for baseline values of the outcome
measure, and (c) for baseline variables which differ to a
clinically significant extent between groups. Differential
effects of the intervention by age, sex and baseline activ-
ity levels will be assessed for the primary outcome mea-
sures by adding terms for the interaction between age,
sex and baseline activity levels and treatment arm to the
regression models.
Multilevel models will be applied to take account of
clustering at the practice level (applicable to all arms of
the study) and practitioner effects which will apply to
differing extents in the OEP arm (due to the effective-
ness of different PSIs) and FaME arm (due to the effec-
tiveness of different PMs). Analyses as recommended by
Roberts [70] and Walwyn and Roberts [71] (2009) will
be applied for this purpose.
While the primary endpoint will be attainment of
recommended exercise levels at 12 months, we will
investigate the profile of exercise attainment at all time
points (0, 6, 12, 18 and 24 months post intervention).
We will carry out repeated measures analysis using gen-
eralised estimating equations which account for the
intra-participant dependency of the repeated measures.
In particular we will investigate evidence for differences
in effect of the interventions at the different time points.
As the study consists of two intervention arms and
one control arm, primary analysis will consist of com-
paring each intervention group with the control group.
No formal adjustment of p-values will be made, since
the sample size has been specifically designed to test
each intervention separately.
The economic analysis will adopt standard techni-
ques of economic appraisal [72]. The measure of effec-
tiveness will be mean differences in QALY scores at
the end of follow up after adjustment for baseline
values, estimated in an analysis of covariance. If statis-
tically significant differences between groups are
found, incremental cost effectiveness ratios will be cal-
culated to show the extra cost incurred per QALY
gained. Comparisons will be conducted between the
usual care group and each type of exercise programme,
and between the two interventions, using group means
of follow-up QALY values after adjusting for baseline
levels. The impact of uncertainties in the estimation of
costs and outcome variables will be explored using one
way and probabilistic sensitivity analysis. Bootstrap
methods will be used to represent uncertainty of esti-
mates, either for constructing confidence intervals or
probability curves.
Sensitivity analyses will investigate the cost-effective-
ness of the interventions for people with different levels
of physical activity, health status and health related qual-
ity of life at baseline. Secondary cost-effectiveness ana-
lyses will be conducted using physical activity and other
outcomes as the measures of effectiveness.
Missing outcome data will be assumed to be “missing
at random” (MAR), conditional on key predictors of
“missingness” (in particular baseline values of the
response variable, treatment arm, and measures of
compliance post randomisation) Multiple imputation
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predictors of “missingness” [73]. A further sensitivity
analysis will be carried out where all who do not
report their exercise levels will be assumed to be non-
exercisers.
The full analysis set will comprise all randomised par-
ticipants for whom one post-baseline assessment of the
primary outcome measure is available. The per-protocol
set will comprise all randomised participants who are
deemed to have no protocol violations. CACE analysis
will be carried out [74].); this seeks to estimate the dif-
ference between compliers in the intervention groups
with those who would have complied in the non-inter-
vention group. The safety set will be all randomised par-
ticipants who undertake at least one OEP session or
FaME class.
Protocol violations
Participants who are randomised to the OEP or FaME
programmes who do not undertake any of the OEP pro-
gramme or attend any FaME classes will be deemed to
be protocol violations.
Risks
Participants will complete a health questionnaire at
recruitment which is sent to their GP to confirm exclu-
sion criteria, prior to commencement of either exercise
programme. Previous evaluation of the OEP showed sig-
nificant reductions in falls and injuries [31] No adverse
effects occurred in previous evaluations of either the
O E Po rF A M Ep r o g r a m m e s[ 3 2 ]. Safe exercise guide-
lines will be followed, pre-exercise assessment will be
conducted and exercise intensity and difficulty will be
increased with caution to minimise the risk of injury.
All participants and their general practitioners will be
informed of the potential risk of injury from any exer-
cise programme in the information documents provided
for participants and practices, so that consent is
obtained with full knowledge of such risks.
Adverse events
A na d v e r s ee v e n t( A E )i sa n yu n f a v o u r a b l ea n du n i n -
tended sign, symptom, syndrome or illness that develops
or worsens during the period of observation in the trial.
This includes:
(1) Exacerbation of a pre-existing illness.
(2) Increase in frequency or intensity of a pre-existing
episodic event or condition.
(3) Condition detected or diagnosed after the interven-
tion even though it may have been present prior to the
start of the study.
(4) Continuous persistent disease or symptoms present
at baseline that worsen following the start of the study.
A Serious Adverse Event (SAE) is any adverse event
occurring following study mandated procedures, having
received the OEP or FaME programmes or usual treat-
ment that results in any of the following outcomes:
(1) Death
(2) A life-threatening adverse event
(3) Inpatient hospitalisation or prolongation of existing
hospitalisation
(4) A disability/incapacity
(5) A congenital anomaly in the offspring of a
participant
Important medical events that may not result in death,
be life-threatening, or require hospitalisation may be
considered a serious adverse event when, based upon
appropriate medical judgment, they may jeopardize the
participant and may require medical or surgical inter-
vention to prevent one of the outcomes listed in this
definition.
All adverse events will be assessed for seriousness,
expectedness and causality. All adverse events will be
recorded and closely monitored until resolution, stabili-
sation, or until it has been shown that the study inter-
vention is not the cause.
Participants will be asked to contact the trial site
immediately in the event of any serious adverse event.
The Chief Investigator shall be informed immediately
and shall determine seriousness and causality in con-
junction with any treating medical practitioners. A ser-
ious adverse event that is deemed directly related to or
suspected to be related to the trial intervention will be
reported to the ethics committee.
Informed consent
Written informed consent will be obtained from all par-
ticipants. The decision regarding participation in the
study is entirely voluntary. The researcher will empha-
size to potential participants that consent regarding
study participation may be withdrawn at any time with-
out penalty or affecting the quality or quantity of their
future medical care, or loss of benefits to which the par-
ticipant is otherwise entitled. No trial-specific interven-
tions will be undertaken before informed consent has
been obtained.
Ethical and organisational review
Ethical approval has been granted to the trial from Not-
tingham Research Ethics Committee 2 (application
number 08/H0408/72). National Health Service (NHS)
Research & Development (R&D) approval has been
granted by NHS Nottinghamshire County and Westmin-
ster, Brent, Hounslow and Barnet PCTs, and will be
sought from other relevant PCTs as practices are
recruited to the study.
Discussion
The ProAct65+ trial is a primary care based exercise
intervention for older people with wide inclusion cri-
teria. The pragmatic trial design replicates the approach
taken in successful primary care trials in New Zealand
[37,63] and differs from the majority of trials which
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continuation of physical activity as its primary outcome.
T h ep r o b l e m st h a tw ea n t i c i p a t ea r e :1 )b i a s e si n
recruitment, with those already exercising at a relatively
high level being more likely to volunteer for this trial; 2)
limited retention of recruits to the study, which we
hope to minimise by relatively frequent but brief contact
with participants after the end of the exercise pro-
grammes; 3) variation in ‘doses’ of exercise promotion,
which we hope to avoid through our quality assurance
processes; and 4) an increase in falls risk, as in previous
studies [37], which we will counter through training of
staff, risk reduction and risk management programmes.
Because the trial will document the levels of activity of
participants, which can be compared with population
norms, and the number screened, the number who are
ineligible and the number who refuse, its findings will
be generalisable. The findings will therefore be impor-
tant for informing policy on exercise promotion and
falls prevention amongst older people. They will be rele-
vant to older people and to policy makers working in
health, social care and leisure arenas, health and social
care commissioners and providers, leisure providers and
charities and voluntary organisations working with older
people.
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